MacroGenics, Inc.
MGNX
$1.39
$0.1310.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 149.96M | 141.33M | 41.02M | 43.36M | 58.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.96M | 141.33M | 41.02M | 43.36M | 58.75M |
| Cost of Revenue | 141.03M | 144.16M | 135.24M | 132.53M | 133.78M |
| Gross Profit | 8.94M | -2.83M | -94.22M | -89.17M | -75.03M |
| SG&A Expenses | 71.05M | 55.80M | 54.10M | 53.37M | 52.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 260.54M | 248.42M | 237.81M | 226.93M | 226.99M |
| Operating Income | -110.58M | -107.09M | -196.79M | -183.57M | -168.24M |
| Income Before Tax | -66.02M | -97.62M | -136.37M | -23.24M | -9.06M |
| Income Tax Expenses | 944.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -66.97 | -97.62 | -136.37 | -23.24 | -9.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.97M | -97.62M | -136.37M | -23.24M | -9.06M |
| EBIT | -110.58M | -107.09M | -196.79M | -183.57M | -168.24M |
| EBITDA | -103.04M | -99.71M | -189.29M | -175.07M | -158.60M |
| EPS Basic | -1.07 | -1.57 | -2.19 | -0.37 | -0.15 |
| Normalized Basic EPS | -1.02 | -0.98 | -1.37 | -0.23 | -0.09 |
| EPS Diluted | -1.08 | -1.58 | -2.20 | -0.39 | -0.16 |
| Normalized Diluted EPS | -1.02 | -0.98 | -1.37 | -0.23 | -0.10 |
| Average Basic Shares Outstanding | 250.48M | 249.74M | 248.98M | 248.20M | 247.71M |
| Average Diluted Shares Outstanding | 250.60M | 249.86M | 249.24M | 248.84M | 248.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |